Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
2014 ◽
Vol 172
(1)
◽
pp. 253-254
◽
2016 ◽
Vol 22
(2)
◽
pp. 125-132
◽
Keyword(s):
2010 ◽
Vol 106
(11)
◽
pp. 1640-1645
◽
2020 ◽
2013 ◽
Vol 111
(8)
◽
pp. 1175-1179
◽